At Truusome AI, quality means more than ingredients; it means reliable systems, measurable outcomes, and scalable impact. Our platforms are validated by extensive clinical and laboratory results, ensuring partners can trust the insights, forecasts, and recommendations they receive. Whether in health, operations, or enterprise strategy, we design solutions that inspire confidence and deliver tangible value.
Our technology integrates seamlessly into existing workflows. Starting with the healthcare sector, our AI recommendation engines forecast essential needs without disrupting your org’s. core processes. Just get API access & start enjoying benefits.
Truusome AI began by addressing nutrient deficiencies linked to widespread health challenges. From that foundation, we are building a proprietary knowledge management and decision-support platform capable of identifying gaps, recommending solutions, and ensuring compliance at scale. We aim to expand this platform far beyond healthcare, to supply chains, consumer goods, Saas, proving its adaptability across industries.
Being techies, we use AI to short-list plants that contain all the good stuff and then combine them to brew up magical potions of health! Okay, maybe we are more wizards than techies. Our products are good for you and for the planet! (without any "*"). So hog it up and feel proud!
As of August 19, 2023, Truusome AI’s proprietary algorithms and platform technology were acquired by Orion Pharmaceuticals & Nutraceuticals (India). Under the terms of the agreement, Orion retains exclusive commercial rights for a period of five years, after which the intellectual property will transition to an open-source framework (subject to mutual agreement). This site provides a static archive of our earlier work, with certain details withheld due to confidentiality obligations under the acquisition terms. For updates regarding the future open-source release, or to explore potential collaborations, please contact us directly.
Hello! This is no longer an interactive chatbot. Use the button below to contact us on WhatsApp if you're interested in accessing our open-source algorithm for drug development after the exclusivity period.